| 43 |
2010 Dong-A Initiated Phase 3 Program of DA-7218 for Oxazolidinone Antibiotic |
2010-09-09 |
| 42 |
Dong-A Launches MONOTAXEL, a cancer treatment |
2010-07-15 |
| 41 |
Dong-A Wraps up Acquisition of Samchully, an API Manufacturer |
2010-07-15 |
| 40 |
OZEX OPHTHALMIC SOLUTION 0.3 PERCENT, Antibiotic Eye Drops, Debuts |
2010-04-14 |
| 39 |
The Most Preferred ZYDENA Comes with Cutting-edge Holography |
2010-01-26 |
| 38 |
Dong-A Pharm Exports Leucostim, a Biologic, to Turkey |
2009-11-11 |
| 37 |
ZYDENA Poised to Enter Global Market with Phase III Clinical Trial Starting for US FDA Approval |
2009-11-11 |
| 36 |
Dong-A Pharmaceutical Acquires a License for a New Arthritis Drug Made of Natural Substance |
2009-07-31 |
| 35 |
“Bright Vision of Dong-A with DA-7218” |
2009-06-19 |
| 34 |
Erectile Dysfunction Treatment ZYDENA Hits the Russian Market |
2009-05-06 |